Regulation of IL-1 and TNF Receptor Expression and Function by Endogenous Macrophage Migration Inhibitory Factor
Myew–Ling Toh(Monash Medical Centre), Eric F. Morand(Novartis (Switzerland)), Daniel Aeberli(Monash Medical Centre), Leilani L. Santos(Royal Women's Hospital), Yuan Yang(Xihua University), Laveena Sharma(Monash Medical Centre), Derek Lacey(Monash Medical Centre), Michael J. Clarkson(Monash Institute of Medical Research), Colin D. Clyne(Hudson Institute of Medical Research)
Cited by 75
Related Papers
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
|New England Journal of Medicine|2019|1.3k
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913
Definition and initial validation of a Lupus Low Disease Activity State (LLDAS)
|Annals of the Rheumatic Diseases|2015|728
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
|Annals of the Rheumatic Diseases|2014|726